Results 191 to 198 of about 2,198,200 (198)
Some of the next articles are maybe not open access.

MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

Science, 2007
The epidermal growth factor receptor (EGFR) kinase inhibitors gefitinib and erlotinib are effective treatments for lung cancers with EGFR activating mutations, but these tumors invariably develop drug resistance.
J. Engelman   +18 more
semanticscholar   +1 more source

Revisions in the International System for Staging Lung Cancer.

Chest, 1997
Revisions in stage grouping of the TNM subsets (T=primary tumor, N=regional lymph nodes, M=distant metastasis) in the International System for Staging Lung Cancer have been adopted by the American Joint Committee on Cancer and the Union Internationale ...
C. Mountain
semanticscholar   +1 more source

The global burden of lung cancer: current status and future trends

Nature Reviews Clinical Oncology, 2023
A. Leiter, R. Veluswamy, J. Wisnivesky
semanticscholar   +1 more source

Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

Nature, 2007
M. Soda   +17 more
semanticscholar   +1 more source

Lung cancer

The Lancet, 2021
A. Thai   +4 more
semanticscholar   +1 more source

End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography

Nature Network Boston, 2019
Diego Ardila   +11 more
semanticscholar   +1 more source

Phenotype molding of stromal cells in the lung tumor microenvironment

Nature Network Boston, 2018
D. Lambrechts   +17 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy